Ionizing radiation and glioblastoma exosomes: Implications in tumor biology and cell migration

Translational Oncology

Volumn 6, Issue 6, 2013, Pages 638-648

  Arscott, W Tris ^a,b,c   Tandle, Anita T ^a   Zhao, Shuping ^a   Shabason, Jacob E ^a,c,d   Gordon, Ira K ^a   Schlaff, Cody D ^a   Zhang, Guofeng ^e   Tofilon, Philip J ^a   Camphausen, Kevin A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIX PROTEIN; CCL23 CHEMOKINE; CCL25 CHEMOKINE; CD9 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; FOCAL ADHESION KINASE; MICRORNA; PAXILLIN; PEPTIDES AND PROTEINS; PLATELET DERIVED GROWTH FACTOR B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; SOMATOMEDIN BINDING PROTEIN 2; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN FAMILY MEMBER 3;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; EXOSOME; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IONIZING RADIATION; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; UPREGULATION;

EID: 84891671335     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13640     Document Type: Article

References (52)

1. Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, and Tofilon PJ (2005). Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proc Natl Acad Sci USA 102, 8287-8292.
2. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, and DeClerck YA (2012). Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 72, 2473-2480.
3. Lotvall J and Valadi H (2007). Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 1, 156-158.
4. Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, and Rak J (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10, 619-624.
5. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, and Breakefield XO (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10, 1470-1476.
6. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, and Skog J (2011). Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2, 180.
7. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B, and Rak J (2011). Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 33, 455-467.
8. Rak J (2010). Microparticles in cancer. Semin Thromb Hemost 36, 888-906.
9. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, and Kohn EC (2012). Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion. Angiogenesis 15, 33-45.
10. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, and Camussi G (2011). Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71, 5346-5356.
11. Peinado H, Aleèkoviæ M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18, 883-891.
12. Putz U, Howitt J, Doan A, Goh CP, Low LH, Silke J, and Tan SS (2012). The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci Signal 5, ra70.
13. McCready J, Sims JD, Chan D, and Jay DG (2010). Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10, 294.
14. Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S, Wang J, Cao X, Grizzle W, and Kimberly RP (2006). A membrane form of TNF-α presented by exosomes delays T cell activation-induced cell death. J Immunol 176, 7385-7393.
15. Taylor DD and Gercel-Taylor C (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110, 13-21.
16. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, and Skog J (2012). RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 12, 22.
17. Agnihotri S, Burrell KE, Wolf A, Jalali S, Hawkins C, Rutka JT, and Zadeh G (2012). Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies. Arch Immunol Ther Exp (Warsz) 1, 25-41.
18. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, et al. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10, 459-466.
19. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, and Sze SK (2010). Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9, 1085-1099.
20. King HW, Michael MZ, and Gleadle JM (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12, 421.
21. + glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res 15, 5145-5153.
22. Théry C, Amigorena S, Raposo G, and Clayton A (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3, Unit 3 22.
23. Soo CY, Song Y, Zheng Y, Campbell EC, Riches AC, Gunn-Moore F, and Powis SJ (2012). Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells. Immunology 136, 192-197.
24. Khatua AK, Taylor HE, Hildreth JE, and Popik W (2009). Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J Virol 83, 512-521.
25. Ohtsu M, Kawate M, Fukuoka M, Gunji W, Hanaoka F, Utsugi T, Onoda F, and Murakami Y (2008). Novel DNA microarray system for analysis of nascent mRNAs. DNA Res 15, 241-251.
26. Goley EM, Anderson SJ, Ménard C, Chuang E, Lü X, Tofilon PJ, and Camphausen K (2004). Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors. BMC Cancer 4, 20.
27. György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al. (2011). Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68, 2667-2688.
28. Camphausen K, Brady KJ, Burgan WE, Cerra MA, Russell JS, Bull EE, and Tofilon PJ (2004). Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of γH2AX foci. Mol Cancer Ther 3, 409-416.
29. Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, and Tofilon PJ (2004). Enhanced radiation-induced cell killing and prolongation of γH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 64, 316-321.
30. Mathivanan S and Simpson RJ (2009). ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000.
31. Kil WJ, Tofilon PJ, and Camphausen K (2012). Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol 7, 25.
32. Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, and Zhang W (2003). Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63, 4315-4321.
33. Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, et al. (2011). Effect of brain-and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103, 1162-1178.
34. Johnson-Holiday C, Singh R, Johnson E, Singh S, Stockard CR, Grizzle WE, and Lillard JW Jr (2011). CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion. Int J Oncol 38, 1279-1285.
35. Hwang J, Son KN, Kim CW, Ko J, Na DS, Kwon BS, Gho YS, and Kim J (2005). Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30, 254-263.
36. Gehmert S, Prantl L, Vykoukal J, Alt E, and Song YH (2010). Breast cancer cells attract the migration of adipose tissue-derived stem cells via the PDGF-BB/ PDGFR-β signaling pathway. Biochem Biophys Res Commun 398, 601-605.
37. Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV, and Cowell JK (2007). Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 170, 2112-2121.
38. Yu X, Harris SL, and Levine AJ (2006). The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res 66, 4795-4801.
39. Lehmann BD, Paine MS, Brooks AM, McCubrey JA, Renegar RH, Wang R, and Terrian DM (2008). Senescence-associated exosome release from human prostate cancer cells. Cancer Res 68, 7864-7871.
40. Chen CC and Lau LF (2009). Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41, 771-783.
41. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, and Zhang W (2007). Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci USA 104, 11736-11741.
42. Hanks SK, Ryzhova L, Shin NY, and Brábek J (2003). Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 8, d982-996.
43. Wooten MW, Vandenplas ML, Seibenhener ML, Geetha T, and Diaz-Meco MT (2001). Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway. Mol Cell Biol 21, 8414-8427.
44. Renshaw MW, Price LS, and Schwartz MA (1999). Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J Cell Biol 147, 611-618.
45. Sodhi A, Montaner S, and Gutkind JS (2004). Viral hijacking of G-proteincoupled-receptor signalling networks. Nat Rev Mol Cell Biol 5, 998-1012.
46. Giaccone G and Zucali PA (2008). Src as a potential therapeutic target in nonsmall-cell lung cancer. Ann Oncol 19, 1219-1223.
47. Mendes KN, Wang GK, Fuller GN, and Zhang W (2010). JNK mediates insulin-like growth factor binding protein 2/integrin α5-dependent glioma cell migration. Int J Oncol 37, 143-153.
48. Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, and Zhang W (2009). IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci USA 106, 16675-16679.
49. Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, and Sawyers CL (2007). Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci USA 104, 5563-5568.
50. Al-Mayah AH, Irons SL, Pink RC, Carter DR, and Kadhim MA (2012). Possible role of exosomes containing RNA in mediating nontargeted effect of ionizing radiation. Radiat Res 177, 539-545.
51. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, and Rak J (2009). Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106, 3794-3799.
52. Marleau AM, Chen CS, Joyce JA, and Tullis RH (2012). Exosome removal as a therapeutic adjuvant in cancer. J Transl Med 10, 134.